Chonluten 20MG (Glu-Asp-Gly, the EDG tripeptide) is a synthetic short peptide bioregulator for transporter docking and sequence-panel research. In a 26-peptide docking survey, Glu-Asp-Gly scored second at the LAT1 amino acid transporter, behind only Glu-Asp-Arg. Supplied as white lyophilized powder in a 20MG vial. CAS 75007-24-8. PubChem CID 194641.
In stock
Chonluten (L-glutamyl-L-aspartyl-glycine, also called Glu-Asp-Gly, EDG, the EDG tripeptide or H-Glu-Asp-Gly-OH; CAS 75007-24-8) is a synthetic tripeptide from the Khavinson family of short peptide bioregulators. It is three amino acids, L-Glutamic acid, L-Aspartic acid and Glycine, joined by two peptide bonds. Chonluten shares the Glu-Asp core found in several other bioregulator sequences, including Glu-Asp-Arg, Ala-Glu-Asp and Ala-Glu-Asp-Leu, and it is the only one of them that ends in Glycine, the smallest amino acid. Its chemistry is set by an acid-heavy charge pattern: one free amine at the N-terminus against three carboxylic acids, on the Glutamic acid and Aspartic acid side chains and at the C-terminus. The best-documented chemistry for Chonluten comes from molecular docking. In a survey of 26 short peptides docked into models of the LAT1, LAT2, PEPT1 and PEPT2 transporters, Glu-Asp-Gly scored −43.40 at LAT1, second of 26 and behind only Glu-Asp-Arg, and the authors list it among the peptides predicted to be stronger LAT1 ligands than the known inhibitors they used as comparators (Khavinson et al., 2023, PMC10046148). These are computed binding scores, not measured transport, and no measured binding constant for Glu-Asp-Gly has been published in the sources we checked.

Batch-verified at Modern Aminos, Chonluten is supplied in one laboratory format:
Laboratories building Glu-Asp sequence panels often place Chonluten next to other public reference listings such as Glu-Asp-Arg, (Ala-Glu-Asp), (Ala-Glu-Asp-Leu) and Cardiogen (Ala-Glu-Asp-Arg), as well as Lys-Glu-Asp. For a side-by-side look at four of these sequences, see Cardiogen vs : Bioregulator Peptide Comparison.
| Compound Name | Chonluten (Glu-Asp-Gly) |
|---|---|
| Research Category | Synthetic tripeptide; Khavinson short peptide bioregulator; LAT and PEPT transporter docking reference compound |
| Quantity / Formats Offered | 20MG Lyophilized Powder (2R Glass Vial) |
| Peptide Sequence | Glu-Asp-Gly (EDG), H-Glu-Asp-Gly-OH |
| Synonyms / Alt Names | EDG; EDG tripeptide; Glutamyl-aspartyl-glycine; L-Glutamyl-L-aspartyl-glycine; T-34 tripeptide; Glycine, N-(N-L-alpha-glutamyl-L-alpha-aspartyl)- |
| CAS Number | 75007-24-8 |
| PubChem CID | 194641 |
| ChEBI ID | CHEBI:162780 |
| DSSTox ID | DTXSID80996513 |
| Chemical Formula | C11H17N3O8 |
| Molecular Weight | 319.27 g/mol |
| Exact Mass | 319.1016 Da |
| IUPAC Name | (4S)-4-amino-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
| InChIKey | DSPQRJXOIXHOHK-WDSKDSINSA-N |
| SMILES Code | C(CC(=O)O)C(C(=O)NC(CC(=O)O)C(=O)NCC(=O)O)N (2 defined stereocenters, both L (S); see the InChIKey) |
Identity fields are drawn from PubChem CID 194641 and ChEBI; purity and quantity values come from the lot certificates in the Certificate of Analysis tab.
The biochemical targets and pathway logic of Chonluten in laboratory research include:
| ICM-Score, LAT1 (rank of 26) | −43.40 (2nd) | −45.32 (1st) | Khavinson 2023, Table 1 |
|---|---|---|---|
| ICM-Score, LAT2 (rank of 26) | −26.82 (8th) | −32.04 (2nd) | Khavinson 2023, Table 3 |
| ICM-Score, PEPT1 (rank of 26) | −18.04 (15th) | −37.59 (1st) | Khavinson 2023, Table 5 |
| ICM-Score, PEPT2 (rank of 26) | −5.20 (10th) | 8.99 (17th) | Khavinson 2023, Table 7 |
| Measured binding constant (Ki or IC50) | not reported | not reported | – |
Peer-reviewed literature on Chonluten 20MG and its Glu-Asp-Gly sequence centers on transporter docking, sequence-motif analysis and chemical identity:
To map transporter docking, sequence length and the effect of the residue after the Glu-Asp core, researchers compare Chonluten against other short peptide bioregulators, including several available at Modern Aminos:
| Compound / Reference | Primary Target Class | Core Mechanism of Action | Research Focus & Profile |
|---|---|---|---|
| Chonluten 20MG (Glu-Asp-Gly, EDG) | Tripeptide bioregulator; Glu-Asp core | Docked LAT1 −43.40 (2nd of 26), LAT2 −26.82, PEPT1 −18.04 | Acidic N-terminal ED motif closed by Glycine; net negative charge |
| Vilon (Lys-Glu, KE) | Dipeptide bioregulator | LAT1 −19.02, LAT2 −23.94, PEPT1 −17.02; measured PEPT1 substrate in separate assays | Shortest member of the family; zwitterionic rather than acid-heavy |
DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.